Aigen Investment Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Aigen Investment Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3K	Buy	+11,426	New	+$23.3K	0.01%	515

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aigen Investment Management's NBP Position: Q2 2026 in Review

Aigen Investment Management opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 11,426 shares worth $22.3K. The stake represents 0.01% of the portfolio and ranks #515 among its holdings.

49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Aigen Investment Management held 11,426 shares of NovaBridge Biosciences American Depositary Shares worth $22.3K as of Q2 2026.
NovaBridge Biosciences American Depositary Shares was a new Aigen Investment Management position in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up 0.01% of Aigen Investment Management's portfolio in Q2 2026, its #515 holding.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.